Infection and type 1 diabetes mellitus - A two edged sword?

Autoimmunity Reviews

Volumn 8, Issue 8, 2009, Pages 682-686

  Goldberg, Elad ^a   Krause, Ilan ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Bacteria; Infections; Type 1 diabetes; Viruses

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

BACTERIAL INFECTION; CYTOLYSIS; CYTOMEGALOVIRUS; ENTEROVIRUS; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MUMPS; NONHUMAN; PATHOGENESIS; REVIEW; RUBELLA; VIRUS INFECTION;

ANIMALS; BACTERIA; CYTOMEGALOVIRUS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; HUMANS; INFECTION;

EID: 67349224990     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.017     Document Type: Review

References (40)

1. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J 10 (2008) 3-7
2. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 23 (2006) 857-866
3. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., Cutolo M., Amital H., Levy Y., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J 10 (2008) 8-12
4. Shoenfeld Y., Blank M., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J 10 (2008) 13-19
5. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 (2002) 911-920
6. Ram M., Anaya J.M., Barzilai O., Izhaky D., Porat Katz B.S., Blank M., et al. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 7 (2008) 621-625
7. Schatz D.A., Barrett D.J., Maclaren N.K., and Riley W.J. Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. Autoimmunity 1 (1988) 45-50
8. Hiemstra H.S., Schloot N.C., van Veelen P.A., Willemen S.J., Franken K.L., van Rood J.J., et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A 98 (2001) 3988-3991
9. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., and Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4 (1998) 781-785
10. King M.L., Shaikh A., Bidwell D., Voller A., and Banatvala J.E. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet 1 (1983) 1397-1399
11. Hyoty H., Hiltunen M., Knip M., Laakkonen M., Vahasalo P., Karjalainen J., et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44 (1995) 652-657
12. Drescher K.M., Kono K., Bopegamage S., Carson S.D., and Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329 (2004) 381-394
13. Flodstrom M., Tsai D., Fine C., Maday A., and Sarvetnick N. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes 52 (2003) 2025-2034
14. Horwitz M.S., Ilic A., Fine C., Balasa B., and Sarvetnick N. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin Immunol 110 (2004) 134-144
15. Pak C.Y., Eun H.M., McArthur R.G., and Yoon J.W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2 (1988) 1-4
16. van der Werf N., Hillebrands J.L., Klatter F.A., Bos I., Bruggeman C.A., and Rozing J. Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin Dev Immunol 10 (2003) 153-160
17. Pak C.Y., Cha C.Y., Rajotte R.V., McArthur R.G., and Yoon J.W. Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 33 (1990) 569-572
18. Hjelmesaeth J., Sagedal S., Hartmann A., Rollag H., Egeland T., Hagen M., et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 47 (2004) 1550-1556
19. Honeyman M.C., Coulson B.S., Stone N.L., Gellert S.A., Goldwater P.N., Steele C.E., et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49 (2000) 1319-1324
20. Blomqvist M., Juhela S., Erkkila S., Korhonen S., Simell T., Kupila A., et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin Exp Immunol 128 (2002) 511-515
21. Graham K.L., Sanders N., Tan Y., Allison J., Kay T.W., and Coulson B.S. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 83 (2008) 6139-6149
22. Hyoty H., Hiltunen M., Reunanen A., Leinikki P., Vesikari T., Lounamaa R., et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia 36 (1993) 1303-1308
23. Numazaki K., Goldman H., Seemayer T.A., Wong I., and Wainberg M.A. Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In Vivo 4 (1990) 49-54
24. Vuorinen T., Nikolakaros G., Simell O., Hyypia T., and Vainionpaa R. Mumps and Coxsackie B3 virus infection of human fetal pancreatic islet-like cell clusters. Pancreas 7 (1992) 460-464
25. Ou D., Mitchell L.A., Metzger D.L., Gillam S., and Tingle A.J. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus. Diabetologia 43 (2000) 750-762
26. Cavallo M.G., Baroni M.G., Toto A., Gearing A.J., Forsey T., Andreani D., et al. Viral infection induces cytokine release by beta islet cells. Immunology 75 (1992) 664-668
27. Pisetsky D.S. The role of innate immunity in the induction of autoimmunity. Autoimmun Rev 8 (2008) 69-72
28. Myers M.A., Hettiarachchi K.D., Ludeman J.P., Wilson A.J., Wilson C.R., and Zimmet P.Z. Dietary microbial toxins and type 1 diabetes. Ann N Y Acad Sci 1005 (2003) 418-422
29. Hettiarachchi K.D., Zimmet P.Z., and Myers M.A. Transplacental exposure to bafilomycin disrupts pancreatic islet organogenesis and accelerates diabetes onset in NOD mice. J Autoimmun 22 (2004) 287-296
30. Brugman S., Klatter F.A., Visser J.T., Wildeboer-Veloo A.C., Harmsen H.J., Rozing J., et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia 49 (2006) 2105-2108
31. Sechi L.A., Paccagnini D., Salza S., Pacifico A., Ahmed N., and Zanetti S. Mycobacterium avium subspecies paratuberculosis bacteremia in type 1 diabetes mellitus: an infectious trigger?. Clin Infect Dis 46 (2008) 148-149
32. Patterson C.C., Carson D.J., and Hadden D.R. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 39 (1996) 1063-1069
33. Sadelain M.W., Qin H.Y., Lauzon J., and Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39 (1990) 583-589
34. Harada M., Kishimoto Y., and Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 8 (1990) 85-89
35. Bras A., and Aguas A.P. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 89 (1996) 20-25
36. Zaccone P., Fehervari Z., Jones F.M., Sidobre S., Kronenberg M., Dunne D.W., et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33 (2003) 1439-1449
37. Oldstone M.B. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J Exp Med 171 (1990) 2077-2089
38. Zaccone P., Raine T., Sidobre S., Kronenberg M., Mastroeni P., and Cooke A. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol 34 (2004) 3246-3256
39. Serreze D.V., Wasserfall C., Ottendorfer E.W., Stalvey M., Pierce M.A., Gauntt C., et al. Diabetes acceleration or prevention by a Coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 79 (2005) 1045-1052
40. Graham K.L., O'Donnell J.A., Tan Y., Sanders N., Carrington E.M., Allison J., et al. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol 81 (2007) 6446-6458